Nevertheless, these analyses were mainly focused on some specific variants of CHEK2 (del1100C, A252G, and I157T); therefore, mutations of other regions of CHEK2 and their association with ovarian cancer pathogenesis still need to be investigated in detail [81]. This evidence concerns the gene CHEK2 and ovarian carcinoma.